EDGAR Filing Documents for 0001104659-23-038374

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001104659-23-038374

Filing Date

2023-03-29

Accepted

2023-03-29 16:53:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM F-3	tm2310691-1_f3.htm	F-3	512309
2	EXHIBIT 5.1	tm2310691d2_ex5-1.htm	EX-5.1	35333
3	EXHIBIT 23.1	tm2310691d2_ex23-1.htm	EX-23.1	2576
4	EXHIBIT 23.2	tm2310691d2_ex23-2.htm	EX-23.2	2573
5	EX-FILING FEES	tm2310691d2_ex-filingfees.htm	EX-FILING FEES	12595
6	GRAPHIC	lg_proqr-4c.jpg	GRAPHIC	37737
7	GRAPHIC	tb_pipeline-4clr.jpg	GRAPHIC	226535
	Complete submission text file	0001104659-23-038374.txt		930547

Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK

Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-270943 | Film No.: 23775916
SIC: 2834 Pharmaceutical Preparations